ID   CD28_HUMAN              Reviewed;         220 AA.
AC   P10747; A8KAC1; Q13964; Q52M23; Q70WG0; Q8NI54; Q8NI55; Q8NI56; Q8WXJ2;
AC   Q9BYV0;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   28-JAN-2026, entry version 231.
DE   RecName: Full=T-cell-specific surface glycoprotein CD28;
DE   AltName: Full=TP44;
DE   AltName: CD_antigen=CD28;
DE   Flags: Precursor;
GN   Name=CD28;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2825196; DOI=10.1073/pnas.84.23.8573;
RA   Aruffo A., Seed B.;
RT   "Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression
RT   system.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:8573-8577(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 3), AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=2162892;
RA   Lee K.P., Taylor C., Petryniak B., Turka L.A., June C.H., Thompson C.B.;
RT   "The genomic organization of the CD28 gene. Implications for the regulation
RT   of CD28 mRNA expression and heterogeneity.";
RL   J. Immunol. 145:344-352(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RX   PubMed=11916166; DOI=10.1016/s0198-8859(01)00354-8;
RA   Deshpande M., Venuprasad K., Parab P.B., Saha B., Mitra D.;
RT   "A novel CD28 mRNA variant and simultaneous presence of various CD28 mRNA
RT   isoforms in human T lymphocytes.";
RL   Hum. Immunol. 63:20-23(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 4 AND 6), AND CHARACTERIZATION
RP   (ISOFORM 3).
RC   TISSUE=Peripheral blood T-cell;
RX   PubMed=11877290; DOI=10.1182/blood.v99.6.2138;
RA   Hanawa H., Ma Y., Mikolajczak S.A., Charles M.L., Yoshida T., Yoshida R.,
RA   Strathdee C.A., Litchfield D.W., Ochi A.;
RT   "A novel costimulatory signaling in human T lymphocytes by a splice variant
RT   of CD28.";
RL   Blood 99:2138-2145(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7).
RA   Gan S.U., Hare J., Krivoshchapov L., Hui K.M., Galea-Lauri J., Farzaneh F.,
RA   Darling D.;
RT   "New human CD28 isoforms generated by a novel splicing event in the
RT   5'UTR.";
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Livingston R.J., Shaffer T., McFarland I., Nguyen C.P., Stanaway I.B.,
RA   Rajkumar N., Johnson E.J., da Ponte S.H., Willa H., Ahearn M.O.,
RA   Bertucci C., Acklestad J., Carroll A., Swanson J., Gildersleeve H.I.,
RA   Nickerson D.A.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Synovium, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-178 (ISOFORM 1).
RX   PubMed=11735222; DOI=10.1006/geno.2001.6655;
RA   Ling V., Wu P.W., Finnerty H.F., Agostino M.J., Graham J.R., Chen S.,
RA   Jussiff J.M., Fisk G.J., Miller C.P., Collins M.;
RT   "Assembly and annotation of human chromosome 2q33 sequence containing the
RT   CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative,
RT   and microarray approaches.";
RL   Genomics 78:155-168(2001).
RN   [12]
RP   FUNCTION.
RX   PubMed=1650475; DOI=10.1073/pnas.88.15.6575;
RA   Gimmi C.D., Freeman G.J., Gribben J.G., Sugita K., Freedman A.S.,
RA   Morimoto C., Nadler L.M.;
RT   "B-cell surface antigen B7 provides a costimulatory signal that induces T
RT   cells to proliferate and secrete interleukin 2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:6575-6579(1991).
RN   [13]
RP   FUNCTION, PHOSPHORYLATION AT TYR-191, INTERACTION WITH GRB2 AND PIK3R1, AND
RP   MUTAGENESIS OF TYR-191.
RX   PubMed=7568038; DOI=10.1073/pnas.92.19.8891;
RA   Raab M., Cai Y.C., Bunnell S.C., Heyeck S.D., Berg L.J., Rudd C.E.;
RT   "p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase,
RT   growth factor receptor-bound protein GRB-2, and T cell-specific protein-
RT   tyrosine kinase ITK: implications for T-cell costimulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:8891-8895(1995).
RN   [14]
RP   FUNCTION.
RX   PubMed=8617933;
RA   Blotta M.H., Marshall J.D., DeKruyff R.H., Umetsu D.T.;
RT   "Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a
RT   costimulatory signal that up-regulates IL-4 synthesis.";
RL   J. Immunol. 156:3133-3140(1996).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH CD80 AND CD86.
RX   PubMed=12196291; DOI=10.1016/s1074-7613(02)00362-x;
RA   Collins A.V., Brodie D.W., Gilbert R.J., Iaboni A., Manso-Sancho R.,
RA   Walse B., Stuart D.I., van der Merwe P.A., Davis S.J.;
RT   "The interaction properties of costimulatory molecules revisited.";
RL   Immunity 17:201-210(2002).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-209, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [17]
RP   FUNCTION (ISOFORM 3), SUBCELLULAR LOCATION (ISOFORM 3), INTERACTION WITH
RP   CD40LG (ISOFORM 3), AND PHOSPHORYLATION (ISOFORM 3).
RX   PubMed=15067037; DOI=10.1084/jem.20031705;
RA   Mikolajczak S.A., Ma B.Y., Yoshida T., Yoshida R., Kelvin D.J., Ochi A.;
RT   "The modulation of CD40 ligand signaling by transmembrane CD28 splice
RT   variant in human T cells.";
RL   J. Exp. Med. 199:1025-1031(2004).
RN   [18]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-71 AND ASN-129.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-linked
RT   cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189 AND TYR-191, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH PRKCQ.
RX   PubMed=21964608; DOI=10.1038/ni.2120;
RA   Kong K.F., Yokosuka T., Canonigo-Balancio A.J., Isakov N., Saito T.,
RA   Altman A.;
RT   "A motif in the V3 domain of the kinase PKC-theta determines its
RT   localization in the immunological synapse and functions in T cells via
RT   association with CD28.";
RL   Nat. Immunol. 12:1105-1112(2011).
RN   [21]
RP   FUNCTION.
RX   PubMed=24665965; DOI=10.1042/bj20140040;
RA   Skaanland S.S., Moltu K., Berge T., Aandahl E.M., Tasken K.;
RT   "T-cell co-stimulation through the CD2 and CD28 co-receptors induces
RT   distinct signalling responses.";
RL   Biochem. J. 460:399-410(2014).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 17-152 IN COMPLEX WITH THE FAB
RP   FRAGMENT OF A MITOGENIC ANTIBODY, DISULFIDE BONDS, AND GLYCOSYLATION AT
RP   ASN-37 AND ASN-105.
RX   PubMed=15696168; DOI=10.1038/ni1170;
RA   Evans E.J., Esnouf R.M., Manso-Sancho R., Gilbert R.J., James J.R., Yu C.,
RA   Fennelly J.A., Vowles C., Hanke T., Walse B., Hunig T., Sorensen P.,
RA   Stuart D.I., Davis S.J.;
RT   "Crystal structure of a soluble CD28-Fab complex.";
RL   Nat. Immunol. 6:271-279(2005).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF 189-196 IN COMPLEX WITH GRB2, AND
RP   INTERACTION WITH GRB2.
RX   PubMed=24098653; DOI=10.1371/journal.pone.0074482;
RA   Higo K., Ikura T., Oda M., Morii H., Takahashi J., Abe R., Ito N.;
RT   "High resolution crystal structure of the Grb2 SH2 domain with a
RT   phosphopeptide derived from CD28.";
RL   PLoS ONE 8:E74482-E74482(2013).
RN   [24] {ECO:0007744|PDB:7PPN}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 183-198, AND DEPHOSPHORYLATION BY
RP   PTPN11.
RX   PubMed=36114179; DOI=10.1038/s41467-022-32918-5;
RA   Zeke A., Takacs T., Sok P., Nemeth K., Kirsch K., Egri P., Poti A.L.,
RA   Bento I., Tusnady G.E., Remenyi A.;
RT   "Structural insights into the pSer/pThr dependent regulation of the SHP2
RT   tyrosine phosphatase in insulin and CD28 signaling.";
RL   Nat. Commun. 13:5439-5439(2022).
RN   [25] {ECO:0007744|PDB:7VU5}
RP   STRUCTURE BY NMR OF 148-188, SUBUNIT, SUBCELLULAR LOCATION, FUNCTION, AND
RP   MUTAGENESIS OF GLY-160 AND ALA-164.
RX   PubMed=35397202; DOI=10.1016/j.str.2022.03.004;
RA   Wu H., Cao R., Wen M., Xue H., OuYang B.;
RT   "Structural characterization of a dimerization interface in the CD28
RT   transmembrane domain.";
RL   Structure 30:803-812.e5(2022).
RN   [26]
RP   VARIANT IMD123 ARG-18, INVOLVEMENT IN IMD123, AND CHARACTERIZATION OF
RP   VARIANT IMD123 ARG-18.
RX   PubMed=34214472; DOI=10.1016/j.cell.2021.06.004;
RA   Beziat V., Rapaport F., Hu J., Titeux M., Bonnet des Claustres M.,
RA   Bourgey M., Griffin H., Bandet E., Ma C.S., Sherkat R., Rokni-Zadeh H.,
RA   Louis D.M., Changi-Ashtiani M., Delmonte O.M., Fukushima T., Habib T.,
RA   Guennoun A., Khan T., Bender N., Rahman M., About F., Yang R., Rao G.,
RA   Rouzaud C., Li J., Shearer D., Balogh K., Al Ali F., Ata M., Dabiri S.,
RA   Momenilandi M., Nammour J., Alyanakian M.A., Leruez-Ville M., Guenat D.,
RA   Materna M., Marcot L., Vladikine N., Soret C., Vahidnezhad H.,
RA   Youssefian L., Saeidian A.H., Uitto J., Catherinot E., Navabi S.S.,
RA   Zarhrate M., Woodley D.T., Jeljeli M., Abraham T., Belkaya S., Lorenzo L.,
RA   Rosain J., Bayat M., Lanternier F., Lortholary O., Zakavi F., Gros P.,
RA   Orth G., Abel L., Pretet J.L., Fraitag S., Jouanguy E., Davis M.M.,
RA   Tangye S.G., Notarangelo L.D., Marr N., Waterboer T., Langlais D.,
RA   Doorbar J., Hovnanian A., Christensen N., Bossuyt X., Shahrooei M.,
RA   Casanova J.L.;
RT   "Humans with inherited T cell CD28 deficiency are susceptible to skin
RT   papillomaviruses but are otherwise healthy.";
RL   Cell 184:3812-3828.e30(2021).
CC   -!- FUNCTION: Receptor that plays a role in T-cell activation,
CC       proliferation, survival and the maintenance of immune homeostasis
CC       (PubMed:1650475, PubMed:7568038). Functions not only as an amplifier of
CC       TCR signals but delivers unique signals that control intracellular
CC       biochemical events that alter the gene expression program of T-cells
CC       (PubMed:24665965). Stimulation upon engagement of its cognate ligands
CC       CD80 or CD86 increases proliferation and expression of various
CC       cytokines in particular IL2 production in both CD4(+) and CD8(+) T-cell
CC       subsets (PubMed:12196291, PubMed:1650475, PubMed:35397202).
CC       Mechanistically, ligation induces recruitment of protein kinase C-
CC       theta/PRKCQ and GRB2 leading to NF-kappa-B activation via both
CC       PI3K/Akt-dependent and -independent pathways (PubMed:21964608,
CC       PubMed:24665965, PubMed:7568038). In conjunction with TCR/CD3 ligation
CC       and CD40L costimulation, enhances the production of IL4 and IL10 in T-
CC       cells (PubMed:8617933). {ECO:0000269|PubMed:12196291,
CC       ECO:0000269|PubMed:1650475, ECO:0000269|PubMed:21964608,
CC       ECO:0000269|PubMed:24665965, ECO:0000269|PubMed:35397202,
CC       ECO:0000269|PubMed:7568038, ECO:0000269|PubMed:8617933}.
CC   -!- FUNCTION: [Isoform 3]: Enhances CD40L-mediated activation of NF-kappa-B
CC       and kinases MAPK8 and PAK2 in T-cells (PubMed:15067037).
CC       {ECO:0000269|PubMed:15067037}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked (PubMed:35397202). Interacts with
CC       DUSP14. Binds to CD80/B7-1 and CD86/B7-2/B70 (PubMed:12196291).
CC       Interacts with GRB2 (PubMed:24098653, PubMed:7568038). Interacts with
CC       PIK3R1 (PubMed:7568038). Interacts with PRKCQ (PubMed:21964608).
CC       {ECO:0000269|PubMed:12196291, ECO:0000269|PubMed:15696168,
CC       ECO:0000269|PubMed:21964608, ECO:0000269|PubMed:24098653,
CC       ECO:0000269|PubMed:35397202, ECO:0000269|PubMed:7568038}.
CC   -!- SUBUNIT: [Isoform 3]: Interacts with CD40LG.
CC       {ECO:0000269|PubMed:15067037}.
CC   -!- INTERACTION:
CC       P10747; P33681: CD80; NbExp=3; IntAct=EBI-4314301, EBI-1031024;
CC       P10747; P42081: CD86; NbExp=2; IntAct=EBI-4314301, EBI-1030956;
CC       P10747; P27986: PIK3R1; NbExp=10; IntAct=EBI-4314301, EBI-79464;
CC       P10747-1; P01552: entB; Xeno; NbExp=5; IntAct=EBI-15945088, EBI-1027464;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:35397202};
CC       Single-pass type I membrane protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Cell surface
CC       {ECO:0000269|PubMed:15067037}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=P10747-1; Sequence=Displayed;
CC       Name=2; Synonyms=CD28-S2;
CC         IsoId=P10747-2; Sequence=VSP_002494;
CC       Name=3; Synonyms=CD28i;
CC         IsoId=P10747-3; Sequence=VSP_002495;
CC       Name=4; Synonyms=CD28-S1;
CC         IsoId=P10747-4; Sequence=VSP_002496;
CC       Name=5;
CC         IsoId=P10747-5; Sequence=VSP_002495, VSP_002497, VSP_002498;
CC       Name=6; Synonyms=CD28-S3;
CC         IsoId=P10747-6; Sequence=VSP_002495, VSP_002499;
CC       Name=7;
CC         IsoId=P10747-7; Sequence=VSP_047701;
CC   -!- TISSUE SPECIFICITY: Expressed in T-cells and plasma cells, but not in
CC       less mature B-cells.
CC   -!- PTM: Phosphorylated by LCK (PubMed:7568038). Dephosphorylated by PTPN11
CC       (PubMed:36114179). {ECO:0000269|PubMed:36114179,
CC       ECO:0000269|PubMed:7568038}.
CC   -!- PTM: [Isoform 3]: Tyrosine phosphorylated induced by CD40LG.
CC       {ECO:0000269|PubMed:15067037}.
CC   -!- DISEASE: Immunodeficiency 123 with HPV-related verrucosis (IMD123)
CC       [MIM:620901]: An autosomal recessive immunologic disorder characterized
CC       by susceptibility to human papilloma virus (HPV) infections and the
CC       development of HPV-related common verrucosis in the first decade of
CC       life. In some patients with HPV2 infection, warts may progress to
CC       severe generalized hyperkeratotic cutaneous papillomatosis with
CC       cutaneous horns ('tree-man' phenotype). In patients with HPV4
CC       infection, warts remains stable and may even regress with age.
CC       {ECO:0000269|PubMed:34214472}. Note=The disease may be caused by
CC       variants affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CD28 entry;
CC       URL="https://en.wikipedia.org/wiki/CD28";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J02988; AAA60581.1; -; mRNA.
DR   EMBL; M37815; AAA51944.1; -; Genomic_DNA.
DR   EMBL; M37812; AAA51944.1; JOINED; Genomic_DNA.
DR   EMBL; M37813; AAA51944.1; JOINED; Genomic_DNA.
DR   EMBL; M37814; AAA51944.1; JOINED; Genomic_DNA.
DR   EMBL; M37815; AAA51945.1; -; Genomic_DNA.
DR   EMBL; M37812; AAA51945.1; JOINED; Genomic_DNA.
DR   EMBL; M37813; AAA51945.1; JOINED; Genomic_DNA.
DR   EMBL; M37814; AAA51945.1; JOINED; Genomic_DNA.
DR   EMBL; AJ295273; CAC29237.1; -; mRNA.
DR   EMBL; AF222341; AAF33792.1; -; mRNA.
DR   EMBL; AF222342; AAF33793.1; -; mRNA.
DR   EMBL; AF222343; AAF33794.1; -; mRNA.
DR   EMBL; AJ517504; CAD57003.1; -; mRNA.
DR   EMBL; EF064755; ABK41938.1; -; Genomic_DNA.
DR   EMBL; AK292986; BAF85675.1; -; mRNA.
DR   EMBL; AK313313; BAG36118.1; -; mRNA.
DR   EMBL; AC125238; AAY24123.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70348.1; -; Genomic_DNA.
DR   EMBL; BC093698; AAH93698.1; -; mRNA.
DR   EMBL; BC112085; AAI12086.1; -; mRNA.
DR   EMBL; AF411057; AAL40931.1; -; Genomic_DNA.
DR   CCDS; CCDS2361.1; -. [P10747-1]
DR   CCDS; CCDS58749.1; -. [P10747-2]
DR   CCDS; CCDS92935.1; -. [P10747-7]
DR   PIR; A39983; RWHU28.
DR   RefSeq; NP_001230006.1; NM_001243077.2. [P10747-4]
DR   RefSeq; NP_001230007.1; NM_001243078.2. [P10747-2]
DR   RefSeq; NP_001397910.1; NM_001410981.1. [P10747-7]
DR   RefSeq; NP_006130.1; NM_006139.4. [P10747-1]
DR   PDB; 1YJD; X-ray; 2.70 A; C=17-152.
DR   PDB; 3WA4; X-ray; 1.35 A; B=189-196.
DR   PDB; 5AUL; X-ray; 1.10 A; B=189-196.
DR   PDB; 5GJH; X-ray; 1.20 A; B/D=189-196.
DR   PDB; 5GJI; X-ray; 0.90 A; B=189-196.
DR   PDB; 6O8D; X-ray; 3.55 A; C=19-136.
DR   PDB; 7PPN; X-ray; 1.90 A; B=183-198.
DR   PDB; 7VU5; NMR; -; A/B=148-188.
DR   PDB; 8S6Z; X-ray; 3.05 A; C/F=19-152.
DR   PDB; 8W2V; NMR; -; A=114-152.
DR   PDBsum; 1YJD; -.
DR   PDBsum; 3WA4; -.
DR   PDBsum; 5AUL; -.
DR   PDBsum; 5GJH; -.
DR   PDBsum; 5GJI; -.
DR   PDBsum; 6O8D; -.
DR   PDBsum; 7PPN; -.
DR   PDBsum; 7VU5; -.
DR   PDBsum; 8S6Z; -.
DR   PDBsum; 8W2V; -.
DR   AlphaFoldDB; P10747; -.
DR   SMR; P10747; -.
DR   BioGRID; 107378; 27.
DR   CORUM; P10747; -.
DR   DIP; DIP-6043N; -.
DR   ELM; P10747; -.
DR   FunCoup; P10747; 343.
DR   IntAct; P10747; 28.
DR   MINT; P10747; -.
DR   STRING; 9606.ENSP00000324890; -.
DR   ChEMBL; CHEMBL5191; -.
DR   GuidetoPHARMACOLOGY; 2863; -.
DR   GlyCosmos; P10747; 5 sites, No reported glycans.
DR   GlyGen; P10747; 5 sites, 4 N-linked glycans (1 site).
DR   iPTMnet; P10747; -.
DR   PhosphoSitePlus; P10747; -.
DR   BioMuta; CD28; -.
DR   DMDM; 115973; -.
DR   MassIVE; P10747; -.
DR   PaxDb; 9606-ENSP00000324890; -.
DR   PeptideAtlas; P10747; -.
DR   ProteomicsDB; 52645; -. [P10747-1]
DR   ProteomicsDB; 52646; -. [P10747-2]
DR   ProteomicsDB; 52647; -. [P10747-3]
DR   ProteomicsDB; 52648; -. [P10747-4]
DR   ProteomicsDB; 68570; -.
DR   ABCD; P10747; 17 sequenced antibodies.
DR   Antibodypedia; 19958; 3197 antibodies from 50 providers.
DR   DNASU; 940; -.
DR   Ensembl; ENST00000324106.9; ENSP00000324890.7; ENSG00000178562.19. [P10747-1]
DR   Ensembl; ENST00000374481.8; ENSP00000363605.4; ENSG00000178562.19. [P10747-2]
DR   Ensembl; ENST00000458610.6; ENSP00000393648.2; ENSG00000178562.19. [P10747-7]
DR   GeneID; 940; -.
DR   KEGG; hsa:940; -.
DR   MANE-Select; ENST00000324106.9; ENSP00000324890.7; NM_006139.4; NP_006130.1.
DR   UCSC; uc002vah.6; human. [P10747-1]
DR   AGR; HGNC:1653; -.
DR   ClinPGx; PA26207; -.
DR   CTD; 940; -.
DR   DisGeNET; 940; -.
DR   GeneCards; CD28; -.
DR   HGNC; HGNC:1653; CD28.
DR   HPA; ENSG00000178562; Group enriched (lymphoid tissue, placenta).
DR   MalaCards; CD28; -.
DR   MIM; 186760; gene.
DR   MIM; 620901; phenotype.
DR   OpenTargets; ENSG00000178562; -.
DR   Orphanet; 2584; Classic mycosis fungoides.
DR   Orphanet; 3162; Sezary syndrome.
DR   VEuPathDB; HostDB:ENSG00000178562; -.
DR   eggNOG; ENOG502SAVP; Eukaryota.
DR   GeneTree; ENSGT00530000063873; -.
DR   HOGENOM; CLU_154699_0_0_1; -.
DR   InParanoid; P10747; -.
DR   OMA; YSHQLQF; -.
DR   OrthoDB; 8654606at2759; -.
DR   PAN-GO; P10747; 5 GO annotations based on evolutionary models.
DR   PhylomeDB; P10747; -.
DR   PathwayCommons; P10747; -.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-164939; Nef mediated downregulation of CD28 cell surface expression.
DR   Reactome; R-HSA-2219530; Constitutive Signaling by Aberrant PI3K in Cancer.
DR   Reactome; R-HSA-389356; Co-stimulation by CD28.
DR   Reactome; R-HSA-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-HSA-389359; CD28 dependent Vav1 pathway.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   SignaLink; P10747; -.
DR   SIGNOR; P10747; -.
DR   Agora; ENSG00000178562; -.
DR   BioGRID-ORCS; 940; 21 hits in 1163 CRISPR screens.
DR   ChiTaRS; CD28; human.
DR   EvolutionaryTrace; P10747; -.
DR   GeneWiki; CD28; -.
DR   GenomeRNAi; 940; -.
DR   Pharos; P10747; Tbio.
DR   PRO; PR:P10747; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P10747; protein.
DR   Bgee; ENSG00000178562; Expressed in lymph node and 99 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0001772; C:immunological synapse; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0098636; C:protein complex involved in cell adhesion; IDA:MGI.
DR   GO; GO:0015026; F:coreceptor activity; TAS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; NAS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IDA:UniProtKB.
DR   GO; GO:0097190; P:apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0035739; P:CD4-positive, alpha-beta T cell proliferation; IEA:Ensembl.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:UniProtKB.
DR   GO; GO:0006959; P:humoral immune response; TAS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0045060; P:negative thymic T cell selection; IEA:Ensembl.
DR   GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; IEA:Ensembl.
DR   GO; GO:2000563; P:positive regulation of CD4-positive, alpha-beta T cell proliferation; IEA:Ensembl.
DR   GO; GO:0001819; P:positive regulation of cytokine production; TAS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0002863; P:positive regulation of inflammatory response to antigenic stimulus; IEA:Ensembl.
DR   GO; GO:0032733; P:positive regulation of interleukin-10 production; IDA:UniProtKB.
DR   GO; GO:0032743; P:positive regulation of interleukin-2 production; IDA:UniProtKB.
DR   GO; GO:0032753; P:positive regulation of interleukin-4 production; IDA:UniProtKB.
DR   GO; GO:0048304; P:positive regulation of isotype switching to IgG isotypes; IEA:Ensembl.
DR   GO; GO:0045840; P:positive regulation of mitotic nuclear division; IDA:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IEA:Ensembl.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IDA:UniProtKB.
DR   GO; GO:0050862; P:positive regulation of T cell receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0045727; P:positive regulation of translation; NAS:UniProtKB.
DR   GO; GO:0045070; P:positive regulation of viral genome replication; NAS:UniProtKB.
DR   GO; GO:0045589; P:regulation of regulatory T cell differentiation; IEA:Ensembl.
DR   GO; GO:0045066; P:regulatory T cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0042110; P:T cell activation; IDA:UniProt.
DR   GO; GO:0031295; P:T cell costimulation; IBA:GO_Central.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IEA:Ensembl.
DR   CDD; cd20925; IgV_CD28; 1.
DR   FunFam; 2.60.40.10:FF:000716; T-cell-specific surface glycoprotein CD28; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   IDEAL; IID00509; -.
DR   InterPro; IPR008093; CD28.
DR   InterPro; IPR040216; CTLA4/CD28.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013106; Ig_V-set.
DR   PANTHER; PTHR11494; CYTOTOXIC T-LYMPHOCYTE PROTEIN; 1.
DR   PANTHER; PTHR11494:SF7; T-CELL-SPECIFIC SURFACE GLYCOPROTEIN CD28; 1.
DR   Pfam; PF15910; V-set_2; 1.
DR   PRINTS; PR01717; CD28ANTIGEN.
DR   SMART; SM00406; IGv; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Disease variant;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Membrane;
KW   Phosphoprotein; Proteomics identification; Receptor; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..18
FT   CHAIN           19..220
FT                   /note="T-cell-specific surface glycoprotein CD28"
FT                   /id="PRO_0000014652"
FT   TOPO_DOM        19..152
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        153..179
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        180..220
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          28..137
FT                   /note="Ig-like V-type"
FT   REGION          198..220
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         189
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         191
FT                   /note="Phosphotyrosine; by LCK"
FT                   /evidence="ECO:0000269|PubMed:7568038,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         209
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:15144186"
FT   CARBOHYD        37
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:15696168"
FT   CARBOHYD        71
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19349973"
FT   CARBOHYD        92
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        105
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:15696168"
FT   CARBOHYD        129
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19349973"
FT   DISULFID        40..112
FT                   /evidence="ECO:0000269|PubMed:15696168"
FT   DISULFID        66..86
FT                   /evidence="ECO:0000269|PubMed:15696168"
FT   VAR_SEQ         1..17
FT                   /note="MLRLLLALNLFPSIQVT -> MPCGLSALIMCPKGMVAVVVAVDDGDSQALA
FT                   (in isoform 7)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_047701"
FT   VAR_SEQ         19..137
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11877290"
FT                   /id="VSP_002494"
FT   VAR_SEQ         40..137
FT                   /note="CKYSYNLFSREFRASLHKGLDSAVEVCVVYGNYSQQLQVYSKTGFNCDGKLG
FT                   NESVTFYLQNLYVNQTDIYFCKIEVMYPPPYLDNEKSNGTIIHVKG -> W (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11877290"
FT                   /id="VSP_002496"
FT   VAR_SEQ         40..124
FT                   /note="CKYSYNLFSREFRASLHKGLDSAVEVCVVYGNYSQQLQVYSKTGFNCDGKLG
FT                   NESVTFYLQNLYVNQTDIYFCKIEVMYPPPYLD -> Y (in isoform 3,
FT                   isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:11877290,
FT                   ECO:0000303|PubMed:11916166"
FT                   /id="VSP_002495"
FT   VAR_SEQ         138..139
FT                   /note="KH -> EE (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:11916166"
FT                   /id="VSP_002497"
FT   VAR_SEQ         140..220
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:11916166"
FT                   /id="VSP_002498"
FT   VAR_SEQ         152..207
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:11877290"
FT                   /id="VSP_002499"
FT   VARIANT         18
FT                   /note="G -> R (in IMD123; likely pathogenic; the underlying
FT                   nucleotide substitution affects splicing; patient-derived
FT                   cells contain normally spliced transcripts with the
FT                   missense variant and aberrant splice transcripts that
FT                   probably undergo nonsense-mediated decay; significantly
FT                   decreased CD28 mRNA levels in homozygous patient-derived T
FT                   cells compared to controls; decreased function in T cell
FT                   activation)"
FT                   /evidence="ECO:0000269|PubMed:34214472"
FT                   /id="VAR_089967"
FT   MUTAGEN         160
FT                   /note="G->Y: About 75% loss of IL2 release."
FT                   /evidence="ECO:0000269|PubMed:35397202"
FT   MUTAGEN         164
FT                   /note="A->L: About 75% loss of IL2 release."
FT                   /evidence="ECO:0000269|PubMed:35397202"
FT   MUTAGEN         191
FT                   /note="Y->F: Greatly reduced phosphorylation by LCK."
FT                   /evidence="ECO:0000269|PubMed:7568038"
FT   STRAND          27..30
FT                   /evidence="ECO:0007829|PDB:1YJD"
FT   STRAND          35..43
FT                   /evidence="ECO:0007829|PDB:1YJD"
FT   STRAND          49..58
FT                   /evidence="ECO:0007829|PDB:1YJD"
FT   STRAND          64..74
FT                   /evidence="ECO:0007829|PDB:1YJD"
FT   STRAND          77..79
FT                   /evidence="ECO:0007829|PDB:1YJD"
FT   STRAND          81..83
FT                   /evidence="ECO:0007829|PDB:1YJD"
FT   STRAND          85..90
FT                   /evidence="ECO:0007829|PDB:1YJD"
FT   STRAND          92..101
FT                   /evidence="ECO:0007829|PDB:1YJD"
FT   HELIX           104..106
FT                   /evidence="ECO:0007829|PDB:1YJD"
FT   STRAND          108..121
FT                   /evidence="ECO:0007829|PDB:1YJD"
FT   STRAND          123..125
FT                   /evidence="ECO:0007829|PDB:1YJD"
FT   STRAND          131..134
FT                   /evidence="ECO:0007829|PDB:1YJD"
FT   HELIX           153..182
FT                   /evidence="ECO:0007829|PDB:7VU5"
SQ   SEQUENCE   220 AA;  25066 MW;  1D9B6552A5878D0F CRC64;
     MLRLLLALNL FPSIQVTGNK ILVKQSPMLV AYDNAVNLSC KYSYNLFSRE FRASLHKGLD
     SAVEVCVVYG NYSQQLQVYS KTGFNCDGKL GNESVTFYLQ NLYVNQTDIY FCKIEVMYPP
     PYLDNEKSNG TIIHVKGKHL CPSPLFPGPS KPFWVLVVVG GVLACYSLLV TVAFIIFWVR
     SKRSRLLHSD YMNMTPRRPG PTRKHYQPYA PPRDFAAYRS
//
